Travelers (NYSE: TRV) CEO sells stock after major option exercise
Rhea-AI Filing Summary
Travelers Companies’ Chairman and CEO Alan D. Schnitzer reported multiple equity transactions in early February 2026. On February 4, 2026, he exercised 216,246 stock options at $126.18 per share, receiving the same number of common shares.
That day, Schnitzer had 160,513 shares withheld to cover obligations at $294.36 per share and sold additional common stock in three blocks: 26,509 shares at $294.1802, 23,078 shares at $295.0001, and 6,146 shares at $295.8154, based on weighted-average pricing ranges. After these trades, he directly owned 260,329.401 shares of Travelers common stock.
Separately, on February 3, 2026, Schnitzer was granted 88,389 stock options with an exercise price of $288.23, exercisable beginning February 3, 2029 and expiring February 3, 2036. The filing also notes 11,091 shares held indirectly by his spouse, for which he disclaims beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 216,246 | $0.00 | $0.00 |
| Exercise | Common Stock | 216,246 | $126.18 | $27.29M |
| Exercise Price or Tax Liability | Common Stock | 160,513 | $294.36 | $47.25M |
| Sale | Common Stock | 26,509 | $294.1802 | $7.80M |
| Sale | Common Stock | 23,078 | $295.0001 | $6.81M |
| Sale | Common Stock | 6,146 | $295.8154 | $1.82M |
| Grant/Award | Stock Options (Right to Buy) | 88,389 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. Represents the weighted average sales price for price increments ranging from $293.605 to $294.60. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F2. Represents the weighted average sales price for price increments ranging from $294.605 to $295.60. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F3. Represents the weighted average sales price for price increments ranging from $295.61 to $295.975. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F4. The Reporting Person disclaims beneficial ownership of these securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.